Selected research
-
Pan-tumor survey of ROS1 fusions detected by next-generation RNA and whole transcriptome sequencing.
BMC cancer
-
Pan-tumor survey of RET fusions as detected by next-generation RNA sequencing identified RET fusion positive colorectal carcinoma as a unique molecular subset.
Translational oncology
-
ERBB family fusions are recurrent and actionable oncogenic targets across cancer types.
Frontiers in oncology